# Vitamin B9 Homocysteine Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/vitamin-b9-homocysteine-meta-analysis-evidence-review
Category: evidence-review
Summary: Vitamin B9 Homocysteine Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are m
Last reviewed: 2026-07-09
Reviewed by: Migaku Evidence Review
# Vitamin B9 Homocysteine Meta-analysis: What the Evidence Says

## Quick Answer

Vitamin B9 Homocysteine Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| B Vitamins and Ocular Health | narrative review | 3 | 2026-03-12 | 10.2147/OPTH.S575752 |
| Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration | preclinical study | 4 | 2025-12-07 | 10.1007/s40123-025-01281-1 |

## What The Sources Report

- It is now both possible and plausible to identify cellular processes and molecular pathways associated with disease and target vitamin-based interventions to counter pathogenic mechanisms. [Johnson Elizabeth J (2026); evidence level 3]
- This narrative review discusses the role of B vitamins in eye health, from the cellular processes in which they participate to the evidence that they modify ocular disease risk. [Johnson Elizabeth J (2026); evidence level 3]
- Two studies, the Age-Related Eye Disease Study (AREDS) and AREDS2, demonstrated that specific combinations of antioxidant vitamins and minerals-particularly those including lutein and zeaxanthin-reduce the risk of progression to late-stage AMD. [Poteet Julie (2025); evidence level 4]
- Emerging evidence highlights the potential role of B vitamins (especially B, B, and B) in both reducing the risk of AMD development and slowing its progression. [Poteet Julie (2025); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For vitamin b9 homocysteine meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Johnson Elizabeth J (2026). B Vitamins and Ocular Health. DOI: 10.2147/OPTH.S575752. PMCID: PMC12990800. PMID: 41847520. License: https://creativecommons.org/licenses/by-nc/4.0/ https://www.dovepress.com/terms.php http://creativecommons.org/licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12990800/
- Poteet Julie (2025). Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration. DOI: 10.1007/s40123-025-01281-1. PMCID: PMC12882887. PMID: 41353670. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This article is licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12882887/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.